Announcing Dexcel Pharma USA, formerly known as Edenbridge Pharmaceuticals, LLC.

About Us

Dexcel Pharma USA

formerly known as Edenbridge Pharmaceuticals, is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products. Our goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable, and accessible alternatives in the healthcare market. Our approach is to work with best-in-class and like-minded industry partners to deliver our products to physicians and patients everywhere.

Founded in 2008, we launched our first product in February 2010 and have sold our commercial products through every major channel of the U.S. prescription pharmaceutical supply chain. In addition, we have a robust product development pipeline that includes 505(b)(2) NDAs, ANDAs, and foreign filings.

2008

Launched first product

2014

First NDA approved

2022

Rebranded to Dexcel Pharma USA

Timeline hex shape
Timeline hex shape
Timeline hex shape
Timeline hex shape
Timeline hex shape
Timeline hex shape

Company founded

2010

First ANDA approved

2021

Acquired by Dexcel Pharma

2024

Timeline hex shape

2008

company founded

Timeline hex shape

2010

launched first product

Timeline hex shape

2014

first ANDA approved

Timeline hex shape

2021

first NDA approved

Timeline hex shape

2022

acquired by Dexcel Pharma USA

Timeline hex shape

2024

rebranded to Dexcel Pharma USA